Other Non-Current Liabilities
Xylem Other Non-Current Liabilities decreased by 26.2% to $234.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.4%, from $264.00M to $234.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -9.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $501.00M | $492.00M | $438.00M | $432.00M | $408.00M | $361.00M | $286.00M | $285.00M | $293.00M | $281.00M | $344.00M | $262.00M | $250.00M | $254.00M | $304.00M | $264.00M | $278.00M | $255.00M | $317.00M | $234.00M |
| QoQ Change | — | -1.8% | -11.0% | -1.4% | -5.6% | -11.5% | -20.8% | -0.3% | +2.8% | -4.1% | +22.4% | -23.8% | -4.6% | +1.6% | +19.7% | -13.2% | +5.3% | -8.3% | +24.3% | -26.2% |
| YoY Change | — | — | — | — | -18.6% | -26.6% | -34.7% | -34.0% | -28.2% | -22.2% | +20.3% | -8.1% | -14.7% | -9.6% | -11.6% | +0.8% | +11.2% | +0.4% | +4.3% | -11.4% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Xylem's other non-current liabilities?
- Xylem (XYL) reported other non-current liabilities of $234.00M in Q1 2026.
- How has Xylem's other non-current liabilities changed year-over-year?
- Xylem's other non-current liabilities decreased by 11.4% year-over-year, from $264.00M to $234.00M.
- What is the long-term trend for Xylem's other non-current liabilities?
- Over 5 years (2020 to 2025), Xylem's other non-current liabilities has grown at a -9.4% compound annual growth rate (CAGR), from $519.00M to $317.00M.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.